India is facing a silent epidemic of non-alcoholic fatty liver disease, especially affecting young people. Around 1 to 3 ...

Individuals with diabetes and hypertension are especially at risk and should undergo screening for NAFLD (Non-Alcoholic Fatty ...

Discover a recent study where the authors propose a strategic push to double the diagnostic rate of at-risk MASH by 2030.

Variants of obesity-related genes influence how much weight patients lose on specific weight loss drugs like liraglutide, two studies report.

which involved around 800 patients treated with semaglutide or placebo on top of standard care and followed for 72 weeks. MASH is a form of non-alcoholic fatty liver disease (NAFLD) that affects ...

Former FDA chief Dr. David Kessler says the new weight-loss drugs are a powerful tool to fight obesity. But they come with ...

In this edition of Open Interest, we look at how the focus on GLP-1 could reduce household dietary intake and grocery bills.

PACKING for her holidays Ann Howard wonders whether to put her bikini into her suitcase. She might have shed three stone after taking fat jabs but she knows deep down that the idea of wearing a ...

Ozempic (semaglutide) helps people with type 2 diabetes ... This hormone prompts the liver to release glucose (sugar) into the bloodstream. Without that hormone, the liver stops dumping sugar ...

Dapagliflozin, a SGLT2 inhibitor used for type 2 diabetes, alleviates steatohepatitis and fibrosis in patients with ...

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...

Semaglutide Treats Liver Disease in Two Thirds of Patients Apr. 30, 2025 — Semaglutide effectively treats liver disease in two thirds of patients, new research has ... Apr. 15, 2025 ...